Competitor Analysis: VEGF Antibodies – Bevacizumab and Ranibizumab Biosimilars and Biosuperiors - Product Thumbnail Image

Competitor Analysis: VEGF Antibodies – Bevacizumab and Ranibizumab Biosimilars and Biosuperiors

  • Report
  • 70 Pages
From
Bladder and Ureter Cancer Drug Development Pipeline Review, 2017 - Product Thumbnail Image

Bladder and Ureter Cancer Drug Development Pipeline Review, 2017

  • Report
  • 150 Pages
From
Antibody Drug Conjugates: Clinical Trial Tracker - Product Thumbnail Image

Antibody Drug Conjugates: Clinical Trial Tracker

  • Clinical Trials
From
Report package: T-Cell Immunotherapy by Bispecific Antibodies and CAR & TCR Engineered T-cells - Product Thumbnail Image

Report package: T-Cell Immunotherapy by Bispecific Antibodies and CAR & TCR Engineered T-cells

  • Report
  • 618 Pages
From
Competitor Analysis: Biosimilar & Biosuperior Therapeutic Antibodies - 2016 Update - Product Thumbnail Image

Competitor Analysis: Biosimilar & Biosuperior Therapeutic Antibodies - 2016 Update

  • Report
  • 462 Pages
From
ADC Contract Manufacturing Market (2nd edition), 2015-2025 - Product Thumbnail Image

ADC Contract Manufacturing Market (2nd edition), 2015-2025

  • Report
  • 208 Pages
From
Programmed Cell Death Protein 1 (CD279 or Systemic Lupus Erythematosus Susceptibility 2 or PD1) - Pipeline Review, H1 2016 - Product Thumbnail Image

Programmed Cell Death Protein 1 (CD279 or Systemic Lupus Erythematosus Susceptibility 2 or PD1) - Pipeline Review, H1 2016

  • Report
  • 181 Pages
From
Bispecific Antibody Therapeutics Market (3rd Edition), 2017-2030 - Product Thumbnail Image

Bispecific Antibody Therapeutics Market (3rd Edition), 2017-2030

  • Report
  • 347 Pages
From
Antibody Drug Conjugates Market (3rd Edition) - Product Thumbnail Image

Antibody Drug Conjugates Market (3rd Edition)

  • Report
  • 357 Pages
From
Cancer Stem Cell Therapies Market, 2017-2030 - Product Thumbnail Image

Cancer Stem Cell Therapies Market, 2017-2030

  • Report
  • 270 Pages
From
Antibody Drug Conjugates Market (4th Edition) 2017-2030 - Product Thumbnail Image

Antibody Drug Conjugates Market (4th Edition) 2017-2030

  • Report
  • 556 Pages
From
Antibody-Drug Conjugates 2016: Perspectives & Opportunities - a Pipeline, Technology, Stakeholder & Business Analysis - Product Thumbnail Image

Antibody-Drug Conjugates 2016: Perspectives & Opportunities - a Pipeline, Technology, Stakeholder & Business Analysis

  • Report
  • 470 Pages
From
Chimeric Antigen Receptor (CAR) T cell Immunotherapy - Competitive Landscape, Pipeline and Market Analysis, 2017 - Product Thumbnail Image

Chimeric Antigen Receptor (CAR) T cell Immunotherapy - Competitive Landscape, Pipeline and Market Analysis, 2017

  • Drug Pipelines
  • 365 Pages
From
Cytotoxic T Lymphocyte Protein 4 (Cytotoxic T Lymphocyte Associated Antigen 4 or CD152 or CTLA4) - Pipeline Review, H1 2018 - Product Thumbnail Image

Cytotoxic T Lymphocyte Protein 4 (Cytotoxic T Lymphocyte Associated Antigen 4 or CD152 or CTLA4) - Pipeline Review, H1 2018

  • Report
  • 141 Pages
From
Head And Neck Cancer - Pipeline Review, H1 2018 - Product Thumbnail Image

Head And Neck Cancer - Pipeline Review, H1 2018

  • Report
  • 1639 Pages
From
Bile Duct Cancer (Cholangiocarcinoma) - Pipeline Review, H2 2017 - Product Thumbnail Image

Bile Duct Cancer (Cholangiocarcinoma) - Pipeline Review, H2 2017

  • Report
  • 766 Pages
From
Anti-CD274 (PD-L1) Antibody -Pipeline Insight, 2018 - Product Thumbnail Image

Anti-CD274 (PD-L1) Antibody -Pipeline Insight, 2018

  • Drug Pipelines
  • 90 Pages
From
Bile Duct Cancer (Cholangiocarcinoma) - Pipeline Review, H1 2017 - Product Thumbnail Image

Bile Duct Cancer (Cholangiocarcinoma) - Pipeline Review, H1 2017

  • Report
  • 609 Pages
From
Cytotoxic T-Lymphocyte Protein 4 (CTLA-4 or CD152) - Pipeline Review, H1 2016 - Product Thumbnail Image

Cytotoxic T-Lymphocyte Protein 4 (CTLA-4 or CD152) - Pipeline Review, H1 2016

  • Report
  • 62 Pages
From
Endometrial Cancer - Pipeline Review, H2 2017 - Product Thumbnail Image

Endometrial Cancer - Pipeline Review, H2 2017

  • Report
  • 647 Pages
From
Loading Indicator
adroll